Evidence map›Paper›PMID 41085624›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Artemis: Mass Spectrometry-Based Identification of MHC-Presented Peptides Across Alleles, Classes, and Species Using Soluble Single-Chain MHC Constructs.

Kathryn A K Finton, Ulysses N Foote-McNabb, Elise C Wilcox, Lisa A Jones, Philip R Gafken, Roland K Strong

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kathryn A K FintonDivision of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Ulysses N Foote-McNabbDivision of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Elise C WilcoxTranslational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Lisa A JonesProteomics & Metabolomics Shared Resource, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Philip R GafkenProteomics & Metabolomics Shared Resource, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Roland K StrongDivision of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA. rstrong@fredhutch.org.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterizationR01AI176563 · NIAID · FRED HUTCHINSON CANCER CENTER · PI Roland K Strong · 2023 to 2026
$3.2M
Acquisition of OrbiTrap Eclipse w/FAIMS mass spectrometerS10OD030225 · OD · FRED HUTCHINSON CANCER CENTER · PI GAFKEN, PHILIP R · 2022 to 2022
$1.1M
NCI NIH HHS P30 CA015704NIAID NIH HHS R01 AI176563NIH HHS S10 OD030225
6 · The paper itself

Abstract

The current "gold standard" for the identification of MHC-restricted peptides is conventional immunoprecipitation/mass spectrometry (MS); however, this approach requires a relatively large amount of sample, complex purification procedures, and computational analyses to assign peptides to individual alleles. Here, we provide instructions for the expression, purification, and MS identification of MHC-presented peptides of human and non-human, classical and non-classical, class I and class II proteins using a readily expressible, soluble, and easily purifiable single-chain dimer construct. This procedure enables the identification of up to tens of thousands of allele-specific peptides per run for peptidomics, ligandomics, therapeutic targeting, and motif analyses. Also included are instructions for construct design, streamlined lentiviral transfection and transduction, and computational methods for high-throughput processing of MS results, yielding high confidence peptide lists, motifs, and multiple analytics.

Indexed as

Antigen PresentationMajor Histocompatibility ComplexMass SpectrometryPeptidesAllelesAnimalsHumansPeptidesEpitope discoveryHLALigandomeMass spectrometryMHCPeptidesPeptidomeSingle-chain dimer

Identifiers

PMID41085624
PMCPMC12798959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.